Brief: Cogent Biosciences Q1 Income From Operations USD -74.933 Million
06/05/2025 13:00
May 06 (Reuters) - Cogent Biosciences Q1 net income USD -71.986 million. Q1 operating expenses USD 74.933 million
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's